<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <title>Nasdaq Trade System - Regeneron Pharmaceuticals, Inc. - Common Stock</title>
    <!-- Latest compiled and minified CSS -->
    <link href="https://cdn.jsdelivr.net/npm/bootstrap@5.3.6/dist/css/bootstrap.min.css" rel="stylesheet"
          integrity="sha384-4Q6Gf2aSP4eDXB8Miphtr37CMZZQ5oXLH2yaXMJ2w8e2ZtHTl7GptT4jmndRuHDT" crossorigin="anonymous">
    <script src="https://cdn.jsdelivr.net/npm/bootstrap@5.3.6/dist/js/bootstrap.bundle.min.js"
            integrity="sha384-j1CDi7MgGQ12Z7Qab0qlWQ/Qqz24Gc6BM0thvEMVjHnfYGF0rmFCozFSxQBxwHKO"
            crossorigin="anonymous"></script>
    <meta name="theme-color" content="#712cf9">
</head>

<body>
<header class="navbar sticky-top bg-dark flex-md-nowrap p-0 shadow" data-bs-theme="dark"><a
        class="navbar-brand col-md-3 col-lg-2 me-0 px-3 fs-6 text-white" href="#">Nasdaq Trade system</a>
</header>


<div class="container-fluid">
    <div class="row">

        <main class="col-md-9 ms-sm-auto col-lg-10 px-md-4">
            <a href="../GameResult.html">Back</a>
            <h1>Regeneron Pharmaceuticals, Inc. - Common Stock</h1>
            <img src="REGN.png" class="img-fluid">
            
            <div class="table-responsive small">
                <table class="table table-striped table-sm">
                    <thead>
                    <tr>
                        <th scope="col">ExecutedOn</th>
                        <th scope="col">Company</th>
                        <th scope="col">Listing</th>
                        <th scope="col">Amount</th>
                        <th scope="col">AtPrice</th>
                        <th scope="col">Total</th>
                    </tr>
                    </thead>
                    <tbody>
                    <tr scope="row">
                        <td>10-02-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>5</td>
                        <td>$616.52</td>
                        <td>$3,082.58</td>
                    </tr>
                    <tr scope="row">
                        <td>11-02-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>-5</td>
                        <td>$636.65</td>
                        <td>-$3,183.25</td>
                    </tr>
                    <tr scope="row">
                        <td>22-02-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>7</td>
                        <td>$601.23</td>
                        <td>$4,208.60</td>
                    </tr>
                    <tr scope="row">
                        <td>23-02-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>-7</td>
                        <td>$607.30</td>
                        <td>-$4,251.11</td>
                    </tr>
                    <tr scope="row">
                        <td>03-03-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>9</td>
                        <td>$609.47</td>
                        <td>$5,485.19</td>
                    </tr>
                    <tr scope="row">
                        <td>04-03-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>-9</td>
                        <td>$618.70</td>
                        <td>-$5,568.30</td>
                    </tr>
                    <tr scope="row">
                        <td>10-03-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>12</td>
                        <td>$628.62</td>
                        <td>$7,543.47</td>
                    </tr>
                    <tr scope="row">
                        <td>11-03-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>-12</td>
                        <td>$640.81</td>
                        <td>-$7,689.70</td>
                    </tr>
                    <tr scope="row">
                        <td>05-04-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>34</td>
                        <td>$689.56</td>
                        <td>$23,445.17</td>
                    </tr>
                    <tr scope="row">
                        <td>06-04-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>-34</td>
                        <td>$706.41</td>
                        <td>-$24,017.85</td>
                    </tr>
                    <tr scope="row">
                        <td>16-06-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>371</td>
                        <td>$555.22</td>
                        <td>$205,984.84</td>
                    </tr>
                    <tr scope="row">
                        <td>17-06-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>-371</td>
                        <td>$579.35</td>
                        <td>-$214,938.30</td>
                    </tr>
                    <tr scope="row">
                        <td>22-06-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>378</td>
                        <td>$585.22</td>
                        <td>$221,214.03</td>
                    </tr>
                    <tr scope="row">
                        <td>23-06-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>-378</td>
                        <td>$605.72</td>
                        <td>-$228,960.51</td>
                    </tr>
                    <tr scope="row">
                        <td>31-08-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>1000</td>
                        <td>$579.46</td>
                        <td>$579,458.19</td>
                    </tr>
                    <tr scope="row">
                        <td>01-09-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>-1000</td>
                        <td>$598.97</td>
                        <td>-$598,974.24</td>
                    </tr>
                    <tr scope="row">
                        <td>07-09-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>1000</td>
                        <td>$594.80</td>
                        <td>$594,795.78</td>
                    </tr>
                    <tr scope="row">
                        <td>08-09-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>-1000</td>
                        <td>$706.90</td>
                        <td>-$706,895.94</td>
                    </tr>
                    <tr scope="row">
                        <td>22-09-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>1000</td>
                        <td>$686.36</td>
                        <td>$686,362.73</td>
                    </tr>
                    <tr scope="row">
                        <td>23-09-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>-1000</td>
                        <td>$695.41</td>
                        <td>-$695,407.71</td>
                    </tr>
                    <tr scope="row">
                        <td>12-10-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>1000</td>
                        <td>$726.05</td>
                        <td>$726,052.98</td>
                    </tr>
                    <tr scope="row">
                        <td>13-10-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>-1000</td>
                        <td>$750.49</td>
                        <td>-$750,485.47</td>
                    </tr>
                    <tr scope="row">
                        <td>31-10-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>1000</td>
                        <td>$746.69</td>
                        <td>$746,685.97</td>
                    </tr>
                    <tr scope="row">
                        <td>01-11-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>-1000</td>
                        <td>$757.82</td>
                        <td>-$757,815.12</td>
                    </tr>
                    <tr scope="row">
                        <td>30-11-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>1000</td>
                        <td>$749.63</td>
                        <td>$749,627.87</td>
                    </tr>
                    <tr scope="row">
                        <td>01-12-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>-1000</td>
                        <td>$759.14</td>
                        <td>-$759,141.48</td>
                    </tr>
                    <tr scope="row">
                        <td>06-12-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>1000</td>
                        <td>$745.41</td>
                        <td>$745,409.48</td>
                    </tr>
                    <tr scope="row">
                        <td>07-12-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>-1000</td>
                        <td>$762.16</td>
                        <td>-$762,163.15</td>
                    </tr>
                    <tr scope="row">
                        <td>19-12-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>1000</td>
                        <td>$719.11</td>
                        <td>$719,112.12</td>
                    </tr>
                    <tr scope="row">
                        <td>20-12-2022</td>
                        <td><a href="../de Jonge Investments.html">de Jonge Investments</a></td>
                        <td>Regeneron Pharmaceuticals, Inc. - Common Stock</td>
                        <td>-1000</td>
                        <td>$731.51</td>
                        <td>-$731,507.93</td>
                    </tr>
                    </tbody>
                </table>
            </div>
        </main>
    </div>
</div>
</body>
</html>